Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

Abstract Background N7‐methylguanosine (m7G) modification is one of the most common
transfer RNA (tRNA) modifications in humans. The precise function and molecular …

Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

Background: Papillary thyroid microcarcinoma (PTMC) typically carries an excellent
prognosis regardless of the treatment option pursued. Radiofrequency ablation (RFA) for …

Liver cirrhosis, the end-stage of every chronic liver disease, is not only the major risk factor
for the development of hepatocellular carcinoma but also a limiting factor for anticancer …

Objective We conducted the first meta-analysis to identify the predictive significance of
baseline blood biomarkers (such as neutrophil to lymphocyte ratio (NLR), early alpha …

Background and Aims The dynamic N6‐methyladenosine (m6A) mRNA modification is
essential for acute stress response and cancer progression. Sublethal heat stress from …

Aim This study aimed to investigate the utility of C-reactive protein (CRP) and alpha-
fetoprotein (AFP) in immunotherapy (CRAFITY) score in hepatocellular carcinoma (HCC) …